Abstract
In this issue of Blood, Mancusi et al demonstrate that haploidentical hematopoietic stem cell transplantation (HSCT) from killer immunoglobulin-like receptor (KIR) ligand-mismatched donors with concomitant activating KIRs reduces nonrelapse mortality (NRM).
Original language | English (US) |
---|---|
Pages (from-to) | 3045-3046 |
Number of pages | 2 |
Journal | Blood |
Volume | 125 |
Issue number | 20 |
DOIs | |
State | Published - May 14 2015 |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology